Verinnogen has created a device to enhance the accuracy and efficiency of pre-clinical studies, ultimately leading to faster breakthroughs in cancer treatments.
Its innovative hand-held device accurately measures 3D objects, such as subcutaneous tumours, reducing operator error.
This profiling tool enables researchers to measure the true biological responses to treatment. It also enables more ethical research by potentially reducing animal usage and improving animal welfare.
Verinnogen is reducing the cost of evaluating cancer therapies and bringing the next-generation of critical cancer treatments to patients faster.
“Cambridge is an exceptional place to start a business, particularly in the life sciences sector. The proximity to world-leading academic research, coupled with a community of forward-thinking companies, provides an ideal environment for innovation.”
Transforming cancer research with Verinnogen’s precision tools
As a member of Cambridge Enterprise’s investment portfolio, Verinnogen is transforming cancer research with their cutting-edge 3D surface profiling technology. Their hand-held device eliminates operator error, ensuring precise and efficient data collection in pre-clinical studies. This innovation aims to speed up the development of new cancer therapies by providing reliable and repeatable results.
One of Verinnogen’s significant achievements is their hand-held 3D measurement device, which accurately estimates tumour volumes in pre-clinical studies. This tool meets a crucial need in cancer research, offering a dependable method for data collection that supports the creation of effective treatments.
Verinnogen Gen2 prototype
Verinnogen’s work has been recognised through their selection as a finalist in the ImagineIF! 2021 competition by the Innovation Forum. Additionally, they have received a grant from Innovate UK, which supports their ongoing research and development efforts. These accolades highlight their potential for securing the funding and resources necessary to advance their groundbreaking work.
Image credits: Verinnogen (Banner), Unsplash (Quote)
